Comparative Evaluation of the efficacy of Autologus melanocyte transfer along with PUVA therapy and PUVA therapy alone in vitiligo patients
Phase 3
- Conditions
- vitiligo.disorders of pigmentation
- Registration Number
- IRCT138706111159N1
- Lead Sponsor
- Iran National Science Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
no treatment method since prior to 6 months ago, age 11-60, treatment history for 3 months
Exclusion criteria: pregnancy, breast feeding, depigmented patch >5 squared cm, active vitiligo, infection on treated site, cloid history, Cobner reaction
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Repigmentation rate. Timepoint: 3 weeks, 3 months, 6 months after treatment. Method of measurement: perfect >90%, good 65-89%, moderate 25-64%, fair <25%.;Side effects. Timepoint: 3 weeks, 3 months, 6 months after treatment. Method of measurement: observation.
- Secondary Outcome Measures
Name Time Method